Fact Meets Function

Effects of an Angiotensin IV Analog on 3-Nitropropionic Acid-Induced Huntington’s Disease-Like Symptoms in Rats.

This study examined the effects of Dihexa, an angiotensin IV analog, on rat models of Huntington’s disease induced by 3-nitropropionic acid exposure. Researchers found that Dihexa treatment reduced motor deficits and protected against neuronal damage in treated animals compared to controls. **Evidence level: Animal model** (Note: The source designation of “Human Clinical” appears inconsistent with the study design, which used rat models rather than human subjects).

Effects of an Angiotensin IV Analog on 3-Nitropropionic Acid-Induced Huntington’s Disease-Like Symptoms in Rats. Read Post »

The development of small molecule angiotensin IV analogs to treat Alzheimer’s and Parkinson’s diseases.

This review article examines the development of small molecule analogs of angiotensin IV, particularly dihexa, as potential therapeutic agents for neurodegenerative diseases including Alzheimer’s and Parkinson’s disease, synthesizing evidence from preclinical research on mechanisms of neuroprotection and cognitive enhancement. The review discusses how these analogs may work through the AT4 receptor pathway to promote neuroplasticity and reduce neuroinflammation, drawing on findings from animal models and in vitro studies, though clinical evidence in human subjects remains limited.

**Evidence level:** Review article synthesizing animal model and in vitro research

The development of small molecule angiotensin IV analogs to treat Alzheimer’s and Parkinson’s diseases. Read Post »

The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system.

This preclinical study (in vitro and animal model evidence) investigated how angiotensin IV-derived peptides, specifically dihexa, enhance cognitive function and synapse formation, finding that these effects depend on activation of the hepatocyte growth factor (HGF)/c-met signaling pathway. Researchers demonstrated that blocking the HGF/c-met system prevented the cognitive and synaptogenic benefits typically observed with these peptides in their experimental models. The findings suggest that the HGF/c-met pathway is a critical mechanism underlying the procognitive effects of angiotensin IV-derived peptides.

The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system. Read Post »

Scroll to Top